
|Articles|January 1, 1998
Supplements and Featured Publications
- A Managed Care Appraisal of Atypical Agents in the Treatment of Psychoses
- Volume 4
- Issue 1 Suppl
Atypical Antipsychotics in the Managed Care Era
Advertisement
Articles in this issue
about 28 years ago
Common Treatment Goals: Switching Antipsychoticsabout 28 years ago
Antipsychotics : Present and Futureabout 28 years ago
CME Quizabout 28 years ago
Selected Abstractsabout 28 years ago
Bibliographyabout 28 years ago
Participating Facultyabout 28 years ago
Introduction - The Routine Use of Atypical Antipsychoticsabout 28 years ago
Atypical Antipsychotics and Formulary Decisionsabout 28 years ago
Chronic Ambulatory Outpatients and Four-Vector ManagementNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
4
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
5









